FLR vs ECG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ECG Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Everus Construction Group, Inc. (ECG) driven by superior Valuation, Growth & Margin while FLR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, FLR trades at 14.9x Forward P/E with 2.1% operating margin (+10.5% YoY revenue) versus ECG at 11.9x Forward P/E and 8.2% operating margin (+40.3% YoY). In options structure, FLR sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro) against ECG sits in BREAKDOWN (5th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | FLR Revenue | ECG Revenue | FLR Op. Margin | ECG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $18.9B | N/A | 2.7% | N/A | FLR |
| FY2019 | $15.4B | N/A | -5.4% | N/A | FLR |
| FY2020 | $15.8B | N/A | -1.5% | N/A | FLR |
| FY2021 | $14.2B | N/A | -1.9% | N/A | FLR |
| FY2022 | $13.7B | $2.70B | 1.5% | 6.1% | ECG |
| FY2023 | $15.5B | $2.85B | 0.9% | 6.7% | ECG |
| FY2024 | $16.3B | $2.85B | 2.8% | 6.7% | ECG |
| FY2025 | $15.5B | $3.75B | -2.4% | 7.1% | ECG |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FLR | ECG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.3B | $4.5B | Larger Scale | FLR |
| Trailing P/E Ratio Valuation | 15.7x | 15.4x | Lower Multiple | ECG |
| Forward P/E Ratio Valuation | 14.9x | 11.9x | Lower Multiple | ECG |
| Revenue Growth (YoY) Growth | +10.5% | +40.3% | Higher Growth | ECG |
| Operating Margin (TTM) Profitability | 2.1% | 8.2% | Higher Margin | ECG |
| Net Profit Margin Profitability | -7.2% | 6.2% | Higher Margin | ECG |
| Return on Equity (ROE) Capital Efficiency | -27.4% | 40.3% | Higher ROE | ECG |
| 52-Week Range Position Momentum | 47% ($39โ$58) | 12% ($70โ$172) | Stronger Trend | FLR |
| Beta / 30D Volatility Risk Regime | 1.65ฮฒ ยท 52% Vol | 2.22ฮฒ ยท 130% Vol | Lower Realized Risk | FLR |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 51.6 / 100 (HOLD) | Higher Composite | ECG |